319 related articles for article (PubMed ID: 17018618)
21. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.
Fan R; Kumaravel TS; Jalali F; Marrano P; Squire JA; Bristow RG
Cancer Res; 2004 Dec; 64(23):8526-33. PubMed ID: 15574758
[TBL] [Abstract][Full Text] [Related]
22. GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells.
Shureiqi I; Jiang W; Fischer SM; Xu X; Chen D; Lee JJ; Lotan R; Lippman SM
Cancer Res; 2002 Feb; 62(4):1178-83. PubMed ID: 11861401
[TBL] [Abstract][Full Text] [Related]
23. Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells.
Angelucci A; Garofalo S; Speca S; Bovadilla A; Gravina GL; Muzi P; Vicentini C; Bologna M
Endocr Relat Cancer; 2008 Mar; 15(1):91-100. PubMed ID: 18310278
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression.
Pidgeon GP; Tang K; Cai YL; Piasentin E; Honn KV
Cancer Res; 2003 Jul; 63(14):4258-67. PubMed ID: 12874035
[TBL] [Abstract][Full Text] [Related]
26. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells.
Yano A; Fujii Y; Iwai A; Kawakami S; Kageyama Y; Kihara K
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6012-7. PubMed ID: 17062674
[TBL] [Abstract][Full Text] [Related]
28. The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer.
Hsu PI; Huang MS; Chen HC; Hsu PN; Lai TC; Wang JL; Lo GH; Lai KH; Tseng CJ; Hsiao M
J Surg Oncol; 2008 Jun; 97(7):609-14. PubMed ID: 18449914
[TBL] [Abstract][Full Text] [Related]
29. Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase.
Ghosh J
Biochem Biophys Res Commun; 2004 Mar; 315(3):624-35. PubMed ID: 14975747
[TBL] [Abstract][Full Text] [Related]
30. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
31. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
Yu CH; Kan SF; Pu HF; Jea Chien E; Wang PS
Cancer Sci; 2008 Dec; 99(12):2467-76. PubMed ID: 19037992
[TBL] [Abstract][Full Text] [Related]
32. Relationship between lipoxygenase and human testicular cancer.
Yoshimura R; Matsuyama M; Mitsuhashi M; Takemoto Y; Tsuchida K; Kawahito Y; Sano H; Nakatani T
Int J Mol Med; 2004 Mar; 13(3):389-93. PubMed ID: 14767568
[TBL] [Abstract][Full Text] [Related]
33. Anticancer effects of licofelone (ML-3000) in prostate cancer cells.
Narayanan NK; Nargi D; Attur M; Abramson SB; Narayanan BA
Anticancer Res; 2007; 27(4B):2393-402. PubMed ID: 17695530
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells.
Hayashi T; Nishiyama K; Shirahama T
Int J Urol; 2006 Aug; 13(8):1086-91. PubMed ID: 16903934
[TBL] [Abstract][Full Text] [Related]
35. Emodin induces apoptosis in human prostate cancer cell LNCaP.
Yu CX; Zhang XQ; Kang LD; Zhang PJ; Chen WW; Liu WW; Liu QW; Zhang JY
Asian J Androl; 2008 Jul; 10(4):625-34. PubMed ID: 18478162
[TBL] [Abstract][Full Text] [Related]
36. 15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size).
Tang DG; Bhatia B; Tang S; Schneider-Broussard R
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):135-46. PubMed ID: 17164141
[TBL] [Abstract][Full Text] [Related]
37. p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms.
Kelly JA; Lucia MS; Lambert JR
Cancer Lett; 2009 May; 277(1):38-47. PubMed ID: 19100681
[TBL] [Abstract][Full Text] [Related]
38. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.
Hoque A; Lippman SM; Wu TT; Xu Y; Liang ZD; Swisher S; Zhang H; Cao L; Ajani JA; Xu XC
Carcinogenesis; 2005 Apr; 26(4):785-91. PubMed ID: 15661803
[TBL] [Abstract][Full Text] [Related]
39. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
Thomas S; Reisman D
Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
